Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned

FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners